An overview of various validated HPLC and LC-MS/MS methods for quantitation of drugs in bile: challenges and considerations

被引:16
|
作者
Srinivas, Nuggehally R. [1 ]
Mullangi, Ramesh [2 ]
机构
[1] Vanthys Pharmaceut Dev Pvt Ltd, Phoenix Pinnacle, Bangalore 560001, Karnataka, India
[2] Jubilant Biosys Ltd, Drug Metab & Pharmacokinet, Ind Suburb, Bangalore 560022, Karnataka, India
关键词
Bile; biological matrices; biliary excretion; review; HPLC; LC-MS/MS; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; INDOCYANINE GREEN; BILIARY-EXCRETION; RAT PLASMA; IN-VITRO; FLUORESCENCE DETECTION; BIOANALYTICAL METHODS; ACTIVE METABOLITE; CYCLOSPORINE-A;
D O I
10.1002/bmc.1532
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Although plasma/serum is the preferred matrix for the characterization of pharmacokinetic parameters, recent years have witnessed the emergence of bile matrix as another tool for refining the pharmacokinetic disposition of drug(s) and the associated metabolite(s). The biliary excretion mechanism represents an important path for drug elimination through feces. Also, there are numerous examples in which bile samples have been shown to concentrate both drug and its metabolite(s) in a much higher proportion as compared with the circulating blood levels and may act as a reservoir for the re-entry of the drug and its metabolite(s) to the systemic circulation once the bile gets drained into the small intestine. Firstly, the review provides a comprehensive overview of various analytical methods that have been adopted for bile sample analysis with a description of extraction steps, chromatography and validation protocol. Secondly, it provides a discussion on bioanalytical related strategies including bile sample collection requirements. Thirdly, a brief discussion on fit-for-use method strategy is also presented to enable an optimum allotment of resources for bile related analysis; and finally, the use of bile matrix in several mechanistic studies to probe efflux mechanisms and/or drug-drug interaction potential has been presented with relevant case studies. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:65 / 81
页数:17
相关论文
共 50 条
  • [31] LC-MS/MS quantitation of polyphenols and secoiridoids in edible olives
    Melliou, E.
    Mitchell, A.
    PLANTA MEDICA, 2012, 78 (11) : 1260 - 1260
  • [32] Simultaneous quantitation of urine aldosterone and tetrahydroaldosterone in healthy Chinese subjects using a validated LC-MS/MS method
    Cheng, Jenny Yeuk Ki
    Lo, Clara Wai Shan
    Chan, Alan Shek Lun
    Luk, Yue Kin
    Tsui, Teresa Kam Chi
    Ho, Chung Shun
    BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (09)
  • [33] Validated LC-MS/MS method for quantitation of demethylbellidifolin in rat plasma and its application to pharmacokinetic and bioavailability studies
    Zhang, Jie
    Yan, Huiyu
    Qu, Xiaoyu
    Zhou, Wei
    BIOMEDICAL CHROMATOGRAPHY, 2018, 32 (02)
  • [34] Development of a validated LC-MS/MS method for the in vitro and in vivo quantitation of sunitinib in glioblastoma cells and cancer patients
    Chatziathanasiadou, Maria, V
    Stylos, Evgenios K.
    Giannopoulou, Efstathia
    Spyridaki, Maria-Helen
    Briasoulis, Evangelos
    Kalofonos, Haralabos P.
    Crook, Tim
    Syed, Nelofer
    Sivolapenko, Gregory B.
    Tzakos, Andreas G.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 164 : 690 - 697
  • [35] Fully Validated LC-MS/MS Assay for the Simultaneous Quantitation of Coadministered Therapeutic Antibodies in Cynomolgus Monkey Serum
    Jiang, Hao
    Zeng, Jianing
    Titsch, Craig
    Voronin, Kimberly
    Akinsanya, Billy
    Luo, Linlin
    Shen, Hongwu
    Desai, Dharmesh D.
    Allentoff, Alban
    Aubry, Anne-Francoise
    DeSilva, Binodh S.
    Arnold, Mark E.
    ANALYTICAL CHEMISTRY, 2013, 85 (20) : 9859 - 9867
  • [36] A validated LC-MS/MS method for simultaneous quantitation of piperacillin, cefazolin, and cefoxitin in rat plasma and twelve tissues
    Sheng, Yi-Hua
    Siemiatkowska, Anna
    Kosicka-Noworzyn, Katarzyna
    Brunetti, Luigi
    Kagan, Leonid
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 248
  • [37] Drugs of abuse quantification using LC-MS/MS
    Gauthier, Jeannette
    Petryayeva, Eleonora
    Nichols, Matthew
    Macri, Joseph
    Potter, Murray
    CLINICAL BIOCHEMISTRY, 2020, 86 : 80 - 80
  • [38] LC-MS/MS analysis of new "internet drugs"
    Stephanson, N.
    Al-Saffar, Y.
    Beck, O.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 484 - 484
  • [39] Anidulafungin—challenges in development and validation of an LC-MS/MS bioanalytical method validated for regulated clinical studies
    Tanja Alebic-Kolbah
    Michael S. Modesitt
    Analytical and Bioanalytical Chemistry, 2012, 404 : 2043 - 2055
  • [40] Configuring HPLC systems for LC-MS
    Wehr, T
    LC GC NORTH AMERICA, 2000, 18 (04) : 406 - +